EQUIFAX INC
EFXNYSE🏆 #503 by market capEarnings Feb 2 · PostUS Equity
$177.29▲ $0.76 (+0.43%)
Market closed · at closeTrack EFX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.4%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$20.75B
Mid Cap
📈Revenue Growth (YoY)
10.9%
Healthy
📊Gross Margin
55.2%
Healthy
💵FCF Margin
16.7%
Healthy
⚖️P/S Ratio
3.2x
Fair
Otter Score
84
Strong
EQUIFAX INC
EFXAnalyst Ratings
Price
$177.29
Total
36
Raised
7
Lowered
6
Avg PT
$190.75
H / L
$245 / $75
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Downgraded | Outperform → Sector Perform | 2026-10-26 | $189.00 | +6.60% |
Argus Research | Upgraded | Hold → Buy | 2026-10-22 | $200.00 | +12.80% |
BMO Capital | Reiterated | Market Perform | 2026-10-21 | $75.00 | −57.70% |
Stifel | Reiterated | Buy | 2026-10-21 | — | — |
Needham | Reiterated | Buy | 2026-10-21 | $210.00 | +18.40% |
Mizuho | Reiterated | Outperform | 2026-10-19 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2026-10-16 | $271.00 | +52.90% |
Morgan Stanley | Reiterated | Overweight | 2026-10-13 | $225.00 | +26.90% |
Barclays | Reiterated | Equal Weight | 2026-10-02 | $155.00 | −12.60% |
Wells Fargo | Reiterated | Overweight | 2026-09-22 | $200.00 | +12.80% |
Rothschild & Co | Upgraded | Neutral → Buy | 2026-08-21 | — | — |
Baird | Reiterated | Outperform | 2026-07-22 | — | — |
UBS | Reiterated | Buy | 2026-07-08 | $215.00 | +21.30% |
B of A Securities | Reiterated | Buy | 2026-05-19 | — | — |
Goldman Sachs | Reiterated | Neutral | 2026-02-09 | $148.00 | −16.50% |
JP Morgan | Reiterated | Overweight | 2026-02-05 | $219.00 | +23.50% |
Citigroup | Reiterated | Buy | 2025-07-23 | $331.00 | +86.70% |
Jefferies | Reiterated | Buy | 2025-01-15 | — | — |
Exane BNP Paribas | Upgraded | Neutral → Outperform | 2024-12-16 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2024-12-12 | — | — |
Evercore ISI Group | Upgraded | In Line → Outperform | 2024-02-13 | — | — |
Truist Securities | Reiterated | Buy | 2024-02-09 | — | — |
Redburn Atlantic | Downgraded | Buy → Neutral | 2024-01-11 | — | — |
Deutsche Bank | Upgraded | Hold → Buy | 2023-12-08 | $201.00 | +13.40% |
Credit Suisse | Reiterated | Outperform | 2023-07-21 | $160.00 | −9.80% |
Atlantic Equities | Upgraded | Neutral → Overweight | 2022-11-15 | $230.00 | +29.70% |
SunTrust Robinson Humphrey | Downgraded | Buy → Hold | 2020-06-09 | — | — |
CFRA | Reiterated | Hold | 2020-04-21 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2020-02-18 | $217.00 | +22.40% |
Bank of America | Reiterated | Underperform | 2019-10-02 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2019-07-26 | — | — |
Argus | Reiterated | Hold | 2017-09-15 | — | — |
William Blair | Reiterated | Outperform | 2016-04-08 | — | — |
Cowen & Co. | Reiterated | Outperform | 2016-03-30 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2014-02-18 | — | — |
Evercore Partners | Upgraded | Equal Weight → Overweight | 2013-02-19 | — | — |
Institution
RBC Capital
Downgraded · Outperform → Sector Perform · 2026-10-26
$189.00
+6.60%
Argus Research
Upgraded · Hold → Buy · 2026-10-22
$200.00
+12.80%
BMO Capital
Reiterated · Market Perform · 2026-10-21
$75.00
−57.70%
Stifel
Reiterated · Buy · 2026-10-21
—
—
Needham
Reiterated · Buy · 2026-10-21
$210.00
+18.40%
Mizuho
Reiterated · Outperform · 2026-10-19
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2026-10-16
$271.00
+52.90%
Morgan Stanley
Reiterated · Overweight · 2026-10-13
$225.00
+26.90%
Barclays
Reiterated · Equal Weight · 2026-10-02
$155.00
−12.60%
Wells Fargo
Reiterated · Overweight · 2026-09-22
$200.00
+12.80%
Rothschild & Co
Upgraded · Neutral → Buy · 2026-08-21
—
—
Baird
Reiterated · Outperform · 2026-07-22
—
—
UBS
Reiterated · Buy · 2026-07-08
$215.00
+21.30%
B of A Securities
Reiterated · Buy · 2026-05-19
—
—
Goldman Sachs
Reiterated · Neutral · 2026-02-09
$148.00
−16.50%
JP Morgan
Reiterated · Overweight · 2026-02-05
$219.00
+23.50%
Citigroup
Reiterated · Buy · 2025-07-23
$331.00
+86.70%
Jefferies
Reiterated · Buy · 2025-01-15
—
—
Exane BNP Paribas
Upgraded · Neutral → Outperform · 2024-12-16
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2024-12-12
—
—
Evercore ISI Group
Upgraded · In Line → Outperform · 2024-02-13
—
—
Truist Securities
Reiterated · Buy · 2024-02-09
—
—
Redburn Atlantic
Downgraded · Buy → Neutral · 2024-01-11
—
—
Deutsche Bank
Upgraded · Hold → Buy · 2023-12-08
$201.00
+13.40%
Credit Suisse
Reiterated · Outperform · 2023-07-21
$160.00
−9.80%
Atlantic Equities
Upgraded · Neutral → Overweight · 2022-11-15
$230.00
+29.70%
SunTrust Robinson Humphrey
Downgraded · Buy → Hold · 2020-06-09
—
—
CFRA
Reiterated · Hold · 2020-04-21
—
—
Stifel Nicolaus
Reiterated · Hold · 2020-02-18
$217.00
+22.40%
Bank of America
Reiterated · Underperform · 2019-10-02
—
—
Stephens & Co.
Reiterated · Equal Weight · 2019-07-26
—
—
Argus
Reiterated · Hold · 2017-09-15
—
—
William Blair
Reiterated · Outperform · 2016-04-08
—
—
Cowen & Co.
Reiterated · Outperform · 2016-03-30
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2014-02-18
—
—
Evercore Partners
Upgraded · Equal Weight → Overweight · 2013-02-19
—
—
One row per institution · price target from the firm's latest published target